mRNA Vaccines for Cancer Activate an Unconventional Immune Pathway

New findings reveal mRNA vaccines engage different dendritic cell subtypes to activate anti-tumor immunity, providing insights to enhance vaccine effectiveness, and personalization.















Post Comment